US 9181231
Pyruvate kinase activators for use for increasing lifetime of the red blood cells and treating anemia
granted A61KA61K31/385A61K31/39
Quick answer
US patent 9181231 (Pyruvate kinase activators for use for increasing lifetime of the red blood cells and treating anemia) held by Agios Pharmaceuticals, Inc. expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Agios Pharmaceuticals, Inc.
- Grant date
- Tue Nov 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 72
- CPC classes
- A61K, A61K31/385, A61K31/39, A61K31/423, A61K31/428